{"id":411774,"date":"2021-01-11T07:33:12","date_gmt":"2021-01-11T12:33:12","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=411774"},"modified":"2021-01-11T07:33:12","modified_gmt":"2021-01-11T12:33:12","slug":"diffusion-pharmaceuticals-to-participate-in-h-c-wainwright-bioconnect-2021-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/diffusion-pharmaceuticals-to-participate-in-h-c-wainwright-bioconnect-2021-conference\/","title":{"rendered":"Diffusion Pharmaceuticals to Participate in H.C. Wainwright BioConnect 2021 Conference"},"content":{"rendered":"
\n

CHARLOTTESVILLE,\u00a0Va., Jan. 11, 2021 (GLOBE NEWSWIRE) — Diffusion Pharmaceuticals Inc.<\/a> (Nasdaq: DFFN)\u00a0(\u201cDiffusion\u201d or \u201cthe Company\u201d), today announced that the Company is participating in the H.C. Wainwright BioConnect 2021 Conference being held virtually January 11-14, 2021. Conference specifics are as follows:<\/p>\n\n\n\n\n
\n Event:<\/strong>\n <\/td>\n\n H.C. Wainwright BioConnect 2021 Conference<\/strong>\n <\/td>\n<\/tr>\n
\n Date:\u00a0<\/strong>\n <\/td>\nJanuary 11-14, 2021<\/td>\n<\/tr>\n
\n Registration:<\/strong>\n <\/td>\n\n https:\/\/hcwevents.com\/bioconnect\/<\/a>\n <\/td>\n<\/tr>\n<\/table>\n

The recorded presentation can be accessed by conference participants and the presentation deck can be accessed on the investor relations section of the Diffusion Pharmaceuticals\u2019 website.<\/p>\n

\n About Diffusion Pharmaceuticals Inc.<\/strong>
\n
Diffusion Pharmaceuticals Inc. is an innovative biopharmaceutical company developing novel therapies that enhance the body\u2019s ability to deliver oxygen to the areas where it is needed most. Diffusion\u2019s lead product candidate, trans sodium crocetinate, is being developed to enhance the diffusion of oxygen to tissues with low oxygen levels, also known as hypoxia, a serious complication of many of medicine\u2019s most intractable and difficult-to-treat conditions. In addition to TSC, our product candidate DFN-529, a novel PI3K\/Akt\/mTOR pathway inhibitor, is in early-stage development. We continue to explore alternatives regarding how best to capitalize upon the value of DFN-529 and our associated intellectual property. For more information, please visit us on the web at www.diffusionpharma.com<\/a>.<\/p>\n

\n Forward-Looking Statements<\/strong>
\n
This press release includes express and implied forward-looking statements. By their nature, forward-looking statements involve risks and uncertainties because they relate to and depend upon, among other things, events, competitive dynamics, and industry change. The Company may, in some cases, use terms such as \u201cbelieves\u201d, \u201cestimates\u201d, \u201canticipates\u201d, \u201cexpects\u201d, \u201cplans\u201d, \u201cintends\u201d, \u201cmay\u201d, \u201ccould\u201d, \u201cmight\u201d, \u201cwill\u201d, \u201cshould\u201d, \u201capproximately\u201d, or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. Although the Company believes that it has a reasonable basis for each forward-looking statement contained herein, as a result of certain risks and uncertainties, known and unknown, the Company\u2019s actual results could differ materially from any intentions, beliefs, projections, outlook, analyses, or expectations expressed herein. Particular risk and uncertainties include, among other things, those related to: the Company\u2019s ability to design, initiate, execute, and complete its ongoing and planned studies evaluating TSC; the Company\u2019s ability to achieve its near-term strategic objectives, in the near-term or at all; the Company\u2019s ability to obtain additional financing; the success and timing of the Company\u2019s clinical trials and preclinical studies, including its ability to enroll subjects in such trials and studies at anticipated rates; the Company\u2019s ability to develop and commercialize TSC or any other product candidate; the ongoing COVID-19 pandemic; general economic, political, business, industry, and market conditions, including the recent United States (\u201dU.S.\u201d) presidential election; and the other factors discussed under the heading \u201cRisk Factors\u201d in the Company\u2019s filings with the U.S. Securities and Exchange Commission (\u201cSEC\u201d). Any forward-looking statements in this press release speak only as of the date hereof (or such earlier date as may be identified) and, except as required by applicable law, rule, or regulation, the Company undertakes no obligation to update any such statements after the date hereof. Comparisons of current and any prior period results are not intended to express any ongoing or future trends or indications of future performance, unless explicitly expressed as such, and should only be viewed as historical data. For all forward-looking statements, the Company claims the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation reform Act of 1995.<\/p>\n

\n
\n Contacts<\/u>
\n <\/strong>\n <\/p>\n

\n Investors:<\/strong>
\n
\n Tiberend Strategic Advisors, Inc.<\/a>
\n
Maureen McEnroe, CFA\/Miriam Miller
(212)\u00a0375-2664\/ (212) 375-2694\u00a0
mmcenroe@tiberend.com<\/a>\/mmiller@tiberend.com<\/a><\/p>\n

\n Media:<\/strong>
\n
Jeffrey Freedman
Rooney Partners
(646) 432-0191
jfreedman@rooneyco.com<\/a>\u00a0<\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

CHARLOTTESVILLE,\u00a0Va., Jan. 11, 2021 (GLOBE NEWSWIRE) — Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN)\u00a0(\u201cDiffusion\u201d or \u201cthe Company\u201d), today announced that the Company is participating in the H.C. Wainwright BioConnect 2021 Conference being held virtually January 11-14, 2021. Conference specifics are as follows: Event: H.C. Wainwright BioConnect 2021 Conference Date:\u00a0 January 11-14, 2021 Registration: https:\/\/hcwevents.com\/bioconnect\/ The recorded presentation can be accessed by conference participants and the presentation deck can be accessed on the investor relations section of the Diffusion Pharmaceuticals\u2019 website. About Diffusion Pharmaceuticals Inc. Diffusion Pharmaceuticals Inc. is an innovative biopharmaceutical company developing novel therapies that enhance the body\u2019s ability to deliver oxygen to the areas where it is needed most. Diffusion\u2019s lead product candidate, trans sodium crocetinate, is being developed to … <\/p>\n

Continue reading “Diffusion Pharmaceuticals to Participate in H.C. Wainwright BioConnect 2021 Conference”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-411774","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nDiffusion Pharmaceuticals to Participate in H.C. Wainwright BioConnect 2021 Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/diffusion-pharmaceuticals-to-participate-in-h-c-wainwright-bioconnect-2021-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Diffusion Pharmaceuticals to Participate in H.C. Wainwright BioConnect 2021 Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"CHARLOTTESVILLE,\u00a0Va., Jan. 11, 2021 (GLOBE NEWSWIRE) — Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN)\u00a0(\u201cDiffusion\u201d or \u201cthe Company\u201d), today announced that the Company is participating in the H.C. Wainwright BioConnect 2021 Conference being held virtually January 11-14, 2021. Conference specifics are as follows: Event: H.C. Wainwright BioConnect 2021 Conference Date:\u00a0 January 11-14, 2021 Registration: https:\/\/hcwevents.com\/bioconnect\/ The recorded presentation can be accessed by conference participants and the presentation deck can be accessed on the investor relations section of the Diffusion Pharmaceuticals\u2019 website. About Diffusion Pharmaceuticals Inc. Diffusion Pharmaceuticals Inc. is an innovative biopharmaceutical company developing novel therapies that enhance the body\u2019s ability to deliver oxygen to the areas where it is needed most. Diffusion\u2019s lead product candidate, trans sodium crocetinate, is being developed to … Continue reading "Diffusion Pharmaceuticals to Participate in H.C. Wainwright BioConnect 2021 Conference"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/diffusion-pharmaceuticals-to-participate-in-h-c-wainwright-bioconnect-2021-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-11T12:33:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMzMwMiMzOTEyMDU2IzIwMjg5NDM=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/diffusion-pharmaceuticals-to-participate-in-h-c-wainwright-bioconnect-2021-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/diffusion-pharmaceuticals-to-participate-in-h-c-wainwright-bioconnect-2021-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Diffusion Pharmaceuticals to Participate in H.C. Wainwright BioConnect 2021 Conference\",\"datePublished\":\"2021-01-11T12:33:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/diffusion-pharmaceuticals-to-participate-in-h-c-wainwright-bioconnect-2021-conference\\\/\"},\"wordCount\":606,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/diffusion-pharmaceuticals-to-participate-in-h-c-wainwright-bioconnect-2021-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMzMwMiMzOTEyMDU2IzIwMjg5NDM=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/diffusion-pharmaceuticals-to-participate-in-h-c-wainwright-bioconnect-2021-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/diffusion-pharmaceuticals-to-participate-in-h-c-wainwright-bioconnect-2021-conference\\\/\",\"name\":\"Diffusion Pharmaceuticals to Participate in H.C. Wainwright BioConnect 2021 Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/diffusion-pharmaceuticals-to-participate-in-h-c-wainwright-bioconnect-2021-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/diffusion-pharmaceuticals-to-participate-in-h-c-wainwright-bioconnect-2021-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMzMwMiMzOTEyMDU2IzIwMjg5NDM=\",\"datePublished\":\"2021-01-11T12:33:12+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/diffusion-pharmaceuticals-to-participate-in-h-c-wainwright-bioconnect-2021-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/diffusion-pharmaceuticals-to-participate-in-h-c-wainwright-bioconnect-2021-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/diffusion-pharmaceuticals-to-participate-in-h-c-wainwright-bioconnect-2021-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMzMwMiMzOTEyMDU2IzIwMjg5NDM=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMzMwMiMzOTEyMDU2IzIwMjg5NDM=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/diffusion-pharmaceuticals-to-participate-in-h-c-wainwright-bioconnect-2021-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Diffusion Pharmaceuticals to Participate in H.C. Wainwright BioConnect 2021 Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Diffusion Pharmaceuticals to Participate in H.C. Wainwright BioConnect 2021 Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/diffusion-pharmaceuticals-to-participate-in-h-c-wainwright-bioconnect-2021-conference\/","og_locale":"en_US","og_type":"article","og_title":"Diffusion Pharmaceuticals to Participate in H.C. Wainwright BioConnect 2021 Conference - Market Newsdesk","og_description":"CHARLOTTESVILLE,\u00a0Va., Jan. 11, 2021 (GLOBE NEWSWIRE) — Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN)\u00a0(\u201cDiffusion\u201d or \u201cthe Company\u201d), today announced that the Company is participating in the H.C. Wainwright BioConnect 2021 Conference being held virtually January 11-14, 2021. Conference specifics are as follows: Event: H.C. Wainwright BioConnect 2021 Conference Date:\u00a0 January 11-14, 2021 Registration: https:\/\/hcwevents.com\/bioconnect\/ The recorded presentation can be accessed by conference participants and the presentation deck can be accessed on the investor relations section of the Diffusion Pharmaceuticals\u2019 website. About Diffusion Pharmaceuticals Inc. Diffusion Pharmaceuticals Inc. is an innovative biopharmaceutical company developing novel therapies that enhance the body\u2019s ability to deliver oxygen to the areas where it is needed most. Diffusion\u2019s lead product candidate, trans sodium crocetinate, is being developed to … Continue reading \"Diffusion Pharmaceuticals to Participate in H.C. Wainwright BioConnect 2021 Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/diffusion-pharmaceuticals-to-participate-in-h-c-wainwright-bioconnect-2021-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-11T12:33:12+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMzMwMiMzOTEyMDU2IzIwMjg5NDM=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/diffusion-pharmaceuticals-to-participate-in-h-c-wainwright-bioconnect-2021-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/diffusion-pharmaceuticals-to-participate-in-h-c-wainwright-bioconnect-2021-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Diffusion Pharmaceuticals to Participate in H.C. Wainwright BioConnect 2021 Conference","datePublished":"2021-01-11T12:33:12+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/diffusion-pharmaceuticals-to-participate-in-h-c-wainwright-bioconnect-2021-conference\/"},"wordCount":606,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/diffusion-pharmaceuticals-to-participate-in-h-c-wainwright-bioconnect-2021-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMzMwMiMzOTEyMDU2IzIwMjg5NDM=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/diffusion-pharmaceuticals-to-participate-in-h-c-wainwright-bioconnect-2021-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/diffusion-pharmaceuticals-to-participate-in-h-c-wainwright-bioconnect-2021-conference\/","name":"Diffusion Pharmaceuticals to Participate in H.C. Wainwright BioConnect 2021 Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/diffusion-pharmaceuticals-to-participate-in-h-c-wainwright-bioconnect-2021-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/diffusion-pharmaceuticals-to-participate-in-h-c-wainwright-bioconnect-2021-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMzMwMiMzOTEyMDU2IzIwMjg5NDM=","datePublished":"2021-01-11T12:33:12+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/diffusion-pharmaceuticals-to-participate-in-h-c-wainwright-bioconnect-2021-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/diffusion-pharmaceuticals-to-participate-in-h-c-wainwright-bioconnect-2021-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/diffusion-pharmaceuticals-to-participate-in-h-c-wainwright-bioconnect-2021-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMzMwMiMzOTEyMDU2IzIwMjg5NDM=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMzMwMiMzOTEyMDU2IzIwMjg5NDM="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/diffusion-pharmaceuticals-to-participate-in-h-c-wainwright-bioconnect-2021-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Diffusion Pharmaceuticals to Participate in H.C. Wainwright BioConnect 2021 Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/411774","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=411774"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/411774\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=411774"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=411774"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=411774"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}